Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Brentuximab Vedotin
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Assistance Publique - Hôpitaux de Paris
P3
BB
(68)
Busulfanum
Childhood Acute Myeloid Leukemia
Washington University School of Medicine
P3
BB
(68)
Calaspargase Pegol
Acute Lymphoblastic Leukemia
Children's Oncology Group
P3
BB
(68)
Capecitabine
Gastroesophageal Junction Adenocarcinoma
I-Mab Biopharma US Limited
P3
BB
(68)
Capecitabine
Metastatic Neoplasm
University of Southern California
P3
BB
(68)
Capecitabine
Rectal Cancer
Tao Zhang
P3
BB
(68)
Capecitabine
Gastric Neoplasm
SUNHO(China)BioPharmaceutical CO., Ltd.
P3
BB
(68)
Carboplatin
Fallopian Tube Clear Cell Adenocarcinoma
NRG Oncology
P3
BB
(68)
Carboplatin
Fallopian Tube Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Carboplatin
Hormone Receptor-Positive Breast Cancer
Avenzo Therapeutics, Inc.
P3
BB
(68)
Carboplatin
Cancer Of Unknown Primary Site
Maastricht University Medical Center
P3
BB
(68)
Cediranib
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Head And Neck Squamous Cell Carcinoma
Akeso
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Estrogen-Receptor Negative Breast Cancer
University of Washington
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Head And Neck Cancer
ImmunityBio, Inc.
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Lung Adenocarcinoma
Guangdong Association of Clinical Trials
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Bladder Transitional Cell Carcinoma
Nagoya University
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Ovarian Cancer
Kalinski, Pawel, MD, PhD
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Pancreatic Neoplasm
Taiho Oncology, Inc.
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Cancer Of Unknown Primary Site
Emory University
P3
BB
(68)
Cis-Diamminedichloroplatinum Ii
Urothelial Carcinoma
Nagoya University
P3
BB
(68)
Cyclophosphamide
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(68)
Cyclophosphamide
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(68)
Cyclophosphamide
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
P3
BB
(68)
Showing 1451 to 1475 of 42,301 assets
Previous
Page 59 of 1693
Next